Boston Clinical Trials

What Boston Clinical Trials does

Boston Clinical Trials (BCT) is a privately-held, independent multi-specialty clinical research site headquartered at 26 Cummins Highway in the Roslindale neighborhood of Boston, Massachusetts, operating from a custom 6,000 sq. ft. facility dedicated exclusively to clinical research. The site executes Phase II-IV trials for pharmaceutical, biotechnology, and CRO sponsors across roughly ten therapeutic areas, including dermatology, gastroenterology, internal medicine, neurology, psychiatry, sexual dysfunction, urology, geriatrics, pain management, cosmetic medicine, and medical devices; publicly named sponsor relationships include Allergan, Bayer, Ardelyx, and Dynogen. Core operating assets are a Board-certified investigator pool (most affiliated with Tufts University School of Medicine and St. Elizabeth's Hospital) supported by Registered Nurse Clinical Coordinators capped at two concurrent trials, a computerized volunteer/participant database backed by local media advertising, dedicated monitor rooms, secure drug and refrigerated storage, PK sampling and ECG equipment, and multi-IRB review coverage through Asentral, Chesapeake, and Copernicus. The site has reportedly conducted 300+ studies over 15+ years and claims to have met or exceeded enrollment targets in every study it has participated in.

BCT's revenue model is professional-services based: sponsors contract the site per study on quote-based terms that are not publicly disclosed, with BCT's compensation tied to study execution, enrollment performance, and data quality rather than per-visit fees to participants. Participant compensation (set by the sponsor and approved by the IRB) flows through BCT but is a sponsor cost, not BCT revenue. The go-to-market is hybrid: a sales-led motion targeting enterprise sponsors through a dedicated "For Sponsors" website section and direct outreach, layered with a direct-to-consumer recruitment motion targeting prospective participants through condition-specific blog content, social media (Facebook, LinkedIn), Jotform enrollment forms, a phone inquiry line, and an opt-in volunteer database. BCT is also a WBENC-certified women-owned business since January 2005 and a STARR-certified site, credentials that align it with sponsor supplier-diversity and site-quality procurement programs. No funding rounds, parent company, acquisitions, or geographic expansion beyond the single Boston facility are disclosed in the source material, and revenue, headcount, and ownership detail remain data gaps.

Name

Boston Clinical Trials

Legal name

Boston Clinical Trials

Website

https://bostontrials.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Short description

Boston Clinical Trials is a privately-held, multi-specialty Phase II-IV clinical research site in Roslindale, Boston, executing industry-sponsored trials across ten therapeutic areas for pharmaceutical and CRO sponsors (including Allergan, Bayer, Ardelyx, and Dynogen) and recruiting participants through its own website, volunteer database, and direct outreach.

Ownership category

akta.pro rank

Product category

Clinical Research Site Services

NAICS

Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151), Scientific Research and Development Services (5417), Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071), Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Clinical Trial Patient Recruitment & Retention (HLAGACAD), Decentralized & Hybrid Trial Site Services (Home Health/Nursing) (HLAGACAH)

Keywords

• Clinical trial services
• Clinical research site
• Phase II-IV trials
• Multi-specialty research
• Patient recruitment services

Headquarters

HQ city

Maussane

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Clinical trial execution services for sponsors: BCT is paid by pharmaceutical companies, CROs, and medical device sponsors to run Phase II-IV clinical trials at its Boston facility across multiple therapeutic areas (dermatology, gastroenterology, internal medicine, neurology, psychiatry, sexual dysfunction, urology, geriatrics, pain management, cosmetic medicine, medical devices). Revenue is contracted/transactional per study, with success tied to enrollment performance and data quality.
2. Participant stipends (flow-through, not BCT revenue): BCT disburses monetary compensation to enrolled participants; the amount per visit is set by the sponsor and approved by the IRB and is documented in the Informed Consent Form. Some studies also include transportation, meals, and childcare. These are study costs paid by the sponsor, not BCT's revenue.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Core offering

Boston Clinical Trials is an independent, multi-specialty clinical research site that conducts Phase II-IV clinical trials for pharmaceutical, biotech, and CRO sponsors across 10+ therapeutic areas (dermatology, gastroenterology, internal medicine, neurology, psychiatry, sexual dysfunction, urology, geriatrics, pain management, cosmetic medicine, and medical devices). It recruits participants through its own volunteer database, website, and outreach, and executes trials from a single 6,000 sq. ft. dedicated facility in Roslindale, Boston, with study-related medical care provided to participants at no cost and compensation for time/travel paid per sponsor terms.

Differentiator

Problem solved

Functional benefit

Products and services

• Multi-Specialty Phase II-IV Clinical Trial Execution Services End-to-end Phase II-IV clinical trial execution for pharmaceutical, biotech, medical device, and CRO sponsors across 10+ therapeutic areas — including dermatology, gastroenterology, internal medicine, neurology, psychiatry, sexual dysfunction, urology, geriatrics, pain management, cosmetic medicine, and medical devices — delivered from a 6,000 sq. ft. dedicated clinical research facility with secure drug and refrigerated storage, PK sampling, ECG, and GCP/HIPAA-compliant operations. Engagements are contracted per study and include participant recruitment via BCT's computerized volunteer database and local media outreach, Board-certified PI oversight, Registered Nurse Clinical Coordination, monitor support, and data quality delivery.

Quantifiable outcome

• 300+ studies conducted across 10 therapeutic areas in 15+ years
• +2 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature3 records

Partnerships

Seven partnerships are on record, tiered operational partner, strategic partner and core.

• Asentral IRBoperational partnerOthersIndependent Institutional Review Board (IRB) listed as a partner and as one of the IRBs whose services BCT uses for clinical trial ethical review. Listed on the homepage under 'Clients & Partners'.
• Chesapeake IRBoperational partnerOthersIndependent IRB listed on the homepage under 'Clients & Partners' and on the Experience page among the IRBs BCT has worked with. Provides ethics and regulatory review for BCT's clinical trials.
• Copernicus IRBoperational partnerOthersIndependent IRB listed on the homepage under 'Clients & Partners'. Provides ethics and regulatory review for BCT's clinical trials.
• STARRstrategic partnerOthersSTARR is a site certification organization; BCT is listed as a STARR-certified site, with links to thestarr.org and thestarr.org/starr-certified-sites/ displayed on the homepage.
• Women's Business Enterprise National Council (WBENC)strategic partnerOthersSince January 2005, BCT has been officially certified by WBENC as a women-owned business, supporting sponsor supplier-diversity initiatives.
• Tufts University School of MedicinecoreStrategic or Co-development PartnerMost BCT Principal Investigators are affiliated with Tufts University School of Medicine (and St. Elizabeth's Hospital), supporting investigator recruitment, academic credibility, and clinical research execution.
• St. Elizabeth's HospitalcoreStrategic or Co-development PartnerMost BCT Principal Investigators are affiliated with St. Elizabeth's Hospital, supporting investigator pipeline and clinical research operations.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Medpace: Mid-to-large CRO executing Phase II–IV trials for biopharma sponsors, including dedicated clinical pharmacology infrastructure. Comparable in selling clinical trial execution services to pharma/biotech, but a full-service CRO rather than a focused single-site operator.
• Syneos Health: Large clinical and commercial solutions provider with site network capabilities. Competes for the same pharma sponsor trial-placement budgets as BCT but operates primarily as a CRO plus site-management organization rather than as a dedicated research site.
• IQVIA: Largest global CRO with a substantial clinical research site footprint (Prime Site Network). Competes with BCT for Phase II–IV trial placement, but as part of a much broader CRO and data-services portfolio rather than a dedicated site specialist.
• ICON plc: Global CRO (post-PRA acquisition) with embedded clinical research sites and a broad site-management offering. Comparable as an enterprise sponsor's go-to partner for Phase II–IV trial execution, though not a dedicated site-only operator.

Direct peers

• CenExel Clinical Research: Clinical research site network (formed from JCC and other site roll-ups) operating dedicated research centers across multiple therapeutic specialties. Comparable on dedicated-facility, multi-PI, multi-specialty Phase II–IV trial execution model.
• Meridien Research: Independent multi-specialty clinical research site organization running Phase II–IV trials in similar therapeutic areas (psychiatry, neurology, GI, dermatology). Closely comparable on dedicated-site, multi-specialty operating model.
• Flourish Research: PE-backed multi-specialty clinical research site network that has rolled up independent sites. Directly comparable to BCT in therapeutic breadth (psychiatry, neurology, GI, dermatology, etc.) and in serving the same pharma/biotech sponsor base.
• Velocity Clinical Research: Multi-site, multi-specialty clinical research site network operating dedicated research facilities under a single management umbrella. Highly comparable to BCT's model of running Phase II–IV trials across multiple therapeutic specialties, but at significantly greater scale and geographic reach.
• Accel Research Sites: Network of dedicated multi-specialty clinical research sites focused on Phase II–IV trials across similar therapeutic areas to BCT (neurology, psychiatry, dermatology, urology, etc.). Direct comparable on site-based, multi-therapeutic trial execution.
• Alcanza Clinical Research: Multi-specialty clinical research site platform running Phase II–IV trials in psychiatry, neurology, dermatology, and other areas closely overlapping BCT's therapeutic footprint. Directly comparable site-network peer.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/bostonclinicaltrials
• LinkedInlinkedin.com/company/boston-clinical-trials/about
• Xx.com/boston_trials

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Boston Clinical Trials